Literature DB >> 1467780

Attitude or access: reasons for not attending mammography in Northern Ireland.

F Kee1, A M Telford, P Donaghy, A O'Doherty.   

Abstract

Maximizing the uptake of mammography among the eligible population will be critical to the success of the national breast cancer screening programme. Although compliance may vary for different reasons from area to area, it has been suggested that making screening clinics more accessible may be an effective means of enhancing uptake. In the present study we undertook 600 interviews with women who had been invited for mammography to determine the main reasons given by women in Northern Ireland for not attending for mammography when invited, how these may have related to access factors and to discover their views on how the service might be improved. The most frequently cited reasons for non-attendance were related to feelings of indifference or ignorance of screening issues and to fear of pain or embarrassment. Although more non-attenders did not have access to private transport, few women (23/600) expressed a preference for more accessible clinics. The fact that non-attenders were more likely not to have had a recent cervical smear, adds weight to the notion that attitudes rather than access played the predominant role in influencing uptake in this sample. We have concluded that investment in flexible mobile screening units cannot replace the continued need for delivering effective advocacy to eligible women.

Entities:  

Mesh:

Year:  1992        PMID: 1467780

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  11 in total

1.  Determinants of non-compliance to recommendations on breast cancer screening among women participating in the French E3N cohort study.

Authors:  Camille Flamant; Estelle Gauthier; Françoise Clavel-Chapelon
Journal:  Eur J Cancer Prev       Date:  2006-02       Impact factor: 2.497

2.  Risk perception and preference for prevention of Alzheimer's disease.

Authors:  Sukyung Chung; Kala Mehta; Martha Shumway; Jennifer Alvidrez; Eliseo J Perez-Stable
Journal:  Value Health       Date:  2009-01-12       Impact factor: 5.725

3.  Self-compression Technique vs Standard Compression in Mammography: A Randomized Clinical Trial.

Authors:  Philippe Henrot; Martine Boisserie-Lacroix; Véronique Boute; Philippe Troufléau; Bruno Boyer; Grégory Lesanne; Véronique Gillon; Emmanuel Desandes; Edith Netter; Maryam Saadate; Anne Tardivon; Christine Grentzinger; Julia Salleron; Guillaume Oldrini
Journal:  JAMA Intern Med       Date:  2019-03-01       Impact factor: 21.873

4.  Factors determining compliance with screening mammography.

Authors:  M D Beaulieu; F Béland; D Roy; M Falardeau; G Hébert
Journal:  CMAJ       Date:  1996-05-01       Impact factor: 8.262

5.  Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database.

Authors:  Philippe Autier; Mathieu Boniol; Anna Gavin; Lars J Vatten
Journal:  BMJ       Date:  2011-07-28

6.  Psychological predictors of attendance at annual breast screening examinations.

Authors:  M V Burton; R Warren; D Price; H Earl
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

7.  The impact of car ownership and public transport usage on cancer screening coverage: Empirical evidence using a spatial analysis in England.

Authors:  Chao Wang
Journal:  J Transp Geogr       Date:  2016-10

8.  Dampening enthusiasm for circulating microRNA in breast cancer.

Authors:  Rom S Leidner; Li Li; Cheryl L Thompson
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

9.  Intermittent attendance at breast cancer screening.

Authors:  Padraic Fleming; Sinead O'Neill; Miriam Owens; Therese Mooney; Patricia Fitzpatrick
Journal:  J Public Health Res       Date:  2013-09-05

10.  Lifetime utilization of mammography among Maltese women: a cross-sectional survey.

Authors:  Danika Marmarà; Vincent Marmarà; Gill Hubbard
Journal:  BMC Public Health       Date:  2018-01-25       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.